$bdx consolidation range ideathis range goes back to 2018 lol but i think it may finally break to the upside.
not even on bullside rsi yet. this has room to run. long term play though and this would just be the initial swing. based on the size of the consolidation, there's a chance for a ~200+% upswing over the next few years
178.59 THB
55.27 B THB
654.07 B THB
286.05 M
About Becton, Dickinson and Company
Sector
Industry
CEO
Thomas E. Polen
Website
Headquarters
Franklin Lakes
Founded
1897
ISIN
TH0842120204
FIGI
BBG01V58FDF6
Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. It operates through the following segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment produces medical technologies and devices that are used to help improve healthcare delivery. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, instruments, and reagent systems to detect infectious diseases, healthcare-associated infections, and cancers. The BD Interventional segment offers vascular, urology, oncology, and surgical specialty products to hospitals, ambulatory surgery centers, individual healthcare professionals, extended care facilities, alternate site facilities, and patients via its Homecare business. The company was founded by Maxwell W. Becton and Fairleigh S. Dickinson in 1897 and is headquartered in Franklin Lakes, NJ.
BDX bouncing from resistance-turned-support levelIn the last few days, BDX has tested the resistance-turned-support level several times and bounced back from it.
RSI is oversold. Earlier, BDX had bounced back when RSI had reached present levels.
A bullish Gartley pattern has formed.
TP1 - 38.2% of AD
TP2 - 61.8% of AD
SL - Just below D
Becton, Dickinson: (BDX) - A Quality Defensive Pick BDX gapping higher and may be breaking out of this 5-year range it's been trading in.
This serial-acquirer is a buy. Over the longer-term, Becton Dickinson has been a solid compounder, and the current valuation represents a reasonable entry point.
Becton, Dickinson is a Medical Instruments provi
See all ideas
BDX4986709
Becton, Dickinson and Company 3.794% 20-MAY-2050Yield to maturity
7.21%
Maturity date
May 20, 2050
BDX4240816
Becton, Dickinson and Company 4.875% 15-MAY-2044Yield to maturity
6.71%
Maturity date
May 15, 2044
BDX4191433
Becton, Dickinson and Company 4.685% 15-DEC-2044Yield to maturity
6.54%
Maturity date
Dec 15, 2044
BDX4986708
Becton, Dickinson and Company 2.823% 20-MAY-2030Yield to maturity
5.22%
Maturity date
May 20, 2030
See all BDX06 bonds